These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 17520544)

  • 1. Risk of transmission associated with live attenuated vaccines given to healthy persons caring for or residing with an immunocompromised patient.
    Kamboj M; Sepkowitz KA
    Infect Control Hosp Epidemiol; 2007 Jun; 28(6):702-7. PubMed ID: 17520544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal live attenuated seasonal influenza vaccine: does not challenge current practice.
    Prescrire Int; 2013 Sep; 22(141):201-4. PubMed ID: 24171209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Vaccination].
    Graubner UB; Liese J; Belohradsky BH
    Klin Padiatr; 2001 Sep; 213 Suppl 1():A77-83. PubMed ID: 11577366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recommendations for live viral and bacterial vaccines in immunodeficient patients and their close contacts.
    ; Shearer WT; Fleisher TA; Buckley RH; Ballas Z; Ballow M; Blaese RM; Bonilla FA; Conley ME; Cunningham-Rundles C; Filipovich AH; Fuleihan R; Gelfand EW; Hernandez-Trujillo V; Holland SM; Hong R; Lederman HM; Malech HL; Miles S; Notarangelo LD; Ochs HD; Orange JS; Puck JM; Routes JM; Stiehm ER; Sullivan K; Torgerson T; Winkelstein J
    J Allergy Clin Immunol; 2014 Apr; 133(4):961-6. PubMed ID: 24582311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization in the adult immunocompromised host.
    Löbermann M; Boršo D; Hilgendorf I; Fritzsche C; Zettl UK; Reisinger EC
    Autoimmun Rev; 2012 Jan; 11(3):212-8. PubMed ID: 21621004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cold-adapted, live attenuated influenza vaccine.
    Glezen WP
    Expert Rev Vaccines; 2004 Apr; 3(2):131-9. PubMed ID: 15056039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Vaccination against varicella].
    Magdzik W
    Przegl Epidemiol; 1995; 49(3):321-4. PubMed ID: 7491430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The status of live viral vaccination in early life.
    Gans HA
    Vaccine; 2013 May; 31(21):2531-7. PubMed ID: 23026688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transmissible vaccines whose dissemination rates vary through time, with applications to wildlife.
    Smithson MW; Basinki AJ; Nuismer SL; Bull JJ
    Vaccine; 2019 Feb; 37(9):1153-1159. PubMed ID: 30686635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children.
    Piedra PA; Gaglani MJ; Kozinetz CA; Herschler GB; Fewlass C; Harvey D; Zimmerman N; Glezen WP
    Pediatrics; 2007 Sep; 120(3):e553-64. PubMed ID: 17698577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling a safer smallpox vaccination regimen, for human immunodeficiency virus type 1-infected patients, in immunocompromised macaques.
    Edghill-Smith Y; Venzon D; Karpova T; McNally J; Nacsa J; Tsai WP; Tryniszewska E; Moniuszko M; Manischewitz J; King LR; Snodgrass SJ; Parrish J; Markham P; Sowers M; Martin D; Lewis MG; Berzofsky JA; Belyakov IM; Moss B; Tartaglia J; Bray M; Hirsch V; Golding H; Franchini G
    J Infect Dis; 2003 Oct; 188(8):1181-91. PubMed ID: 14551889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Live viral vaccines in transplanted patients.
    L'Huillier AG; Posfay Barbe K
    Swiss Med Wkly; 2014; 144():w14005. PubMed ID: 25341637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Live attenuated vaccines: Historical successes and current challenges.
    Minor PD
    Virology; 2015 May; 479-480():379-92. PubMed ID: 25864107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. State of the art: Could nursing mothers be vaccinated with attenuated live virus vaccine?
    Alain S; Dommergues MA; Jacquard AC; Caulin E; Launay O
    Vaccine; 2012 Jul; 30(33):4921-6. PubMed ID: 22659446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the immune responses in BALB/c mice following immunization with DNA-based and live attenuated vaccines delivered via different routes.
    Cai MS; Deng SX; Li ML
    Vaccine; 2013 Feb; 31(9):1353-6. PubMed ID: 22995858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Live attenuated and inactivated viral vaccine formulation and nasal delivery: potential and challenges.
    Tlaxca JL; Ellis S; Remmele RL
    Adv Drug Deliv Rev; 2015 Oct; 93():56-78. PubMed ID: 25312673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Better vaccinations - new approaches for targeted immunomodulation in healthy and immunosuppressed].
    Balmer ML; Berger CT
    Ther Umsch; 2014 Jan; 71(1):5-15. PubMed ID: 24394204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of tolerance and effectiveness of a varicella vaccine in leukemic children.
    Bancillon A; Leblanc T; Baruchel A; Schaison G; Leverger G; Mallarmey D; Teuliere L
    Nouv Rev Fr Hematol (1978); 1991; 33(6):555-6. PubMed ID: 1667953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the efficacy and duration of immunity of a canine combination vaccine against virulent parvovirus, infectious canine hepatitis virus, and distemper virus experimental challenges.
    Abdelmagid OY; Larson L; Payne L; Tubbs A; Wasmoen T; Schultz R
    Vet Ther; 2004; 5(3):173-86. PubMed ID: 15578450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination against acute respiratory virus infections and measles in man.
    Osterhaus AD; de Vries P
    Immunobiology; 1992 Feb; 184(2-3):180-92. PubMed ID: 1587542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.